MAS1L and metabolic dysfunction-associated steatohepatitis: We show that MASH, compared to MASL, is characterized by higher levels of serum lipids (i.e., desmosterol, cholesterol, CE, LPC, LPE, PC, PE, and some lipid species) of which several show great potential for distinguishing patients with MASH from MASL, particularly when combined with ALT.